Tyrosinemia Model

Autoimmune Disease Models
Autoimmune Nephropathy ModelsAsthma ModelsSystemic Lupus Erythematosus (SLE) ModelsSjögren's Syndrome ModelsAutoimmune Dermatoses Models Neuroimmune Disease ModelsInflammatory Bowel Disease (IBD) ModelsRheumatoid Arthritis ModelsImmune Reconstitution Autoimmune Disease Models
Metabolic Disease Mouse Models
Obesity ModelsDiabetes ModelsAndrogenetic Alopecia (AGA) ModelsMASH ModelsChronic Liver Fibrosis ModelsAcute Liver Injury ModelsChronic Kindey Disease (CKD) ModelsCholestasis ModelsAlcohol-related Liver Disease (ALD) ModelsActue Kindey Disease (AKD) ModelsDiabetes Nephropathy (Diabetic Kidney Disease) ModelsOsteoporosis ModelsSarcopenia ModelsGout/Hyperuricemia ModelsFemale Reproduction Models
Wild Mouse 750
Wild Mouse 750
Rare Disease Mouse Models
Hemophilia ModelsProgressive Familial Intrahepatic Cholestasis ModelsAutosomal Dominant Polycystic Kidney Disease (ADPKD)Glycogen Storage Disease type 1a ModelGrowth Failure ModelsFabry Disease ModelsHepatolenticular Degeneration ModelNiemann-Pick Disease (Sphingomyelinosis) ModelsHypophosphatasia ModelGM2 Gangliosidoses ModelPulmonary Alveolar Proteinosis ModelLimb Girdle Muscular Dystrophies ModelMaple Syrup Urine Disease ModelMucopolysaccharidosis ModelsHutchinson-Gilford Progeria Syndrome ModelPhenylketonuria/Hyperphenylalaninemia ModelsUrea Cycle Disorders ModelsTyrosinemia ModelThalassemia Models
Neurological Disease Mouse Models
Alzheimer's Disease (AD) ModelsHumanized Alzheimer's Disease (AD) ModelsParkinson's Disease (PD) ModelsHuntington's Disease (HD) ModelsAmyotrophic Lateral Sclerosis (ALS) ModelsTransthyretin Amyloidosis (ATTR) ModelsPain Mouse ModelsDuchenne Muscular Dystrophy (DMD) Models
Oncology Mouse Models
Human Xenograft ModelsDrug ResistanceT-Cell EngagersHumanized Immune Checkpoint ModelsHumanized Immune System ModelsSpontaneous Tumor Models
Cardiovascular Disease Mouse Models
Heart Failure ModelsHypertension ModelsAtherosclerosis ModelsAdvanced Cardiovascular and Metabolic Complication ModelsHyperlipidemia ModelsHypertropic Cardiomyopathy ModelsStroke ModelsThrombosis Models
Humanized Immune System Models
huPBMC-NCGhuHSC-NCG-XhuHSC-NCG-hIL15huHSC-NCG
Organs or Tissue Humanized Mouse Models
Wild Mouse 765
Wild Mouse 765

Tyrosinemia is a metabolic disorder characterized by elevated plasma tyrosine levels resulting from defects in enzymes of the tyrosine metabolic pathway and is classified into three types. Type I, an autosomal recessive disorder with a global incidence of 1 in 120,000 - 1 in 100,000, is caused by a deficiency in fumarate acetoacetate hydrolase (FAH). This enzyme, mainly expressed in the liver and kidneys at the end of the tyrosine degradation pathway, normally breaks down fumarate acetoacetate (FAA) into fumarate and acetoacetate. Genetic mutations that impede or disrupt FAH synthesis cause FAA and its derivative, succinylacetone, to accumulate, leading to hepatic, renal, and neurological symptoms.

 

● Genetically Engineered Tyrosinemia Mouse Model

Strain No.
 Strain Name Strain Type Description
T052634 Fah-KO Knock-out Homozygous Fah-KO mice can only survive with NTBC dosing in drinking water. After NTBC withdral at 9 weeks of age, homozygous mice gradually develop impaired liver function and loss of body weight, which is attenuated by recovery of NTBC treatment. Plasma tyrosine concentration in 12-week-old homozygous mice after 4 weeks of NTBC withdral displays an over 3 fold increase compared to wildtype littermates, which jointly indicates the phenotype of tyrosinemia